SPARC and prostate carcinoma: In a proposed mechanism involving SPARC-integrin interaction, SPARC upregulates VEGF expression and autocrine stimulation of prostate cancer cell growth via VEGF-VEGFR2 signaling.42 Such a mechanism could lead to a large increase in VEGF expression that could also effect overall vascularity by disrupting vessel integrity.